BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10915243)

  • 1. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
    MacQueen KM; Buchbinder SP; Douglas JM; Judson FN; McKirnan DJ; Bartholow BN
    AIDS Public Policy J; 1996; 11(2):104-12. PubMed ID: 10915243
    [No Abstract]   [Full Text] [Related]  

  • 2. The decision to enroll in HIV vaccine efficacy trials: concerns elicited from gay men at increased risk for HIV infection.
    MacQueen KM; Buchbinder S; Douglas JM; Judson FN; McKirnan DJ; Bartholow B
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S261-4. PubMed ID: 7865314
    [No Abstract]   [Full Text] [Related]  

  • 3. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
    Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
    Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials.
    Douglas JM; Judson FN; Parks JP; Buchbinder S; McKirnan D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S257-60. PubMed ID: 7865313
    [No Abstract]   [Full Text] [Related]  

  • 5. Unique risks to volunteers in HIV vaccine trials.
    Frey SE
    J Investig Med; 2003 Feb; 51 Suppl 1():S18-20. PubMed ID: 12664950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The psychosocial approach to the planning and implementation of vaccine trials for HIV infection].
    Starace F; Embrione F; Fusco ML; Cafaro L
    Ann Ist Super Sanita; 2003; 39(2):259-66. PubMed ID: 14587226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
    Temoshok LR
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral studies relevant to vaccine trial preparation: an introduction.
    Turner CF; Sheon AR
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S273-6. PubMed ID: 7865317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domestic AIDS vaccine trials: addressing the potential for social harm to the subjects of human experiments.
    Leider PA
    Calif Law Rev; 2000; 88():1185-232. PubMed ID: 11067733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.
    Chesney MA; Lurie P; Coates TJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):30-5. PubMed ID: 7712232
    [No Abstract]   [Full Text] [Related]  

  • 11. Driving the epidemic underground? A new look at law and the social risk of HIV testing.
    Burris S
    AIDS Public Policy J; 1997; 12(2):66-78. PubMed ID: 10915258
    [No Abstract]   [Full Text] [Related]  

  • 12. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
    Allen M; Lau CY
    Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to HIV testing and confidentiality: the concerns of HIV-positive and high-risk individuals.
    Solomon L; Landrigan J; Flynn C; Benjamin GC
    AIDS Public Policy J; 1999; 14(4):147-56. PubMed ID: 11148945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some ethical issues associated with HIV vaccine trials.
    Novick A
    AIDS Public Policy J; 1988; 3(3):46-8. PubMed ID: 11650102
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
    Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
    AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to participate in HIV vaccine research in a peri-urban South African community.
    Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
    Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS and insurance: the case against HIV antibody testing.
    Scherzer M
    AIDS Public Policy J; 1987; 2(1):19-24. PubMed ID: 11650060
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine trial needs subjects.
    AIDS Patient Care STDS; 2002 May; 16(5):244. PubMed ID: 12058702
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the knowledge and beliefs of Finnish medical students regarding HIV infection and participation in AIDS vaccine trials.
    Onigbogi OO; Kauhanen J; Miettola EJ
    Int Q Community Health Educ; 2005-2006; 24(2):123-34. PubMed ID: 17686682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?
    Newman PA; Duan N; Rudy ET; Anton PA
    AIDS Patient Care STDS; 2004 Dec; 18(12):691-701. PubMed ID: 15659880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.